MA48455B1 - ANTITUMOR COMPOUNDS - Google Patents

ANTITUMOR COMPOUNDS

Info

Publication number
MA48455B1
MA48455B1 MA48455A MA48455A MA48455B1 MA 48455 B1 MA48455 B1 MA 48455B1 MA 48455 A MA48455 A MA 48455A MA 48455 A MA48455 A MA 48455A MA 48455 B1 MA48455 B1 MA 48455B1
Authority
MA
Morocco
Prior art keywords
antitumor compounds
antitumor
compounds
cancer
compound
Prior art date
Application number
MA48455A
Other languages
French (fr)
Other versions
MA48455A (en
Inventor
Marchante Maria Del Carmen Cuevas
Solloso Andres Francesch
Barrasa Valentin Martinez
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Priority claimed from PCT/EP2018/060868 external-priority patent/WO2018197663A1/en
Publication of MA48455A publication Critical patent/MA48455A/en
Publication of MA48455B1 publication Critical patent/MA48455B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne un composé de formule générale i, dans laquelle r1 à r4 ont diverses significations, et est destiné à être utilisé dans le traitement du cancer.The present invention relates to a compound of general formula i, in which r1 to r4 have various meanings, and is intended for use in the treatment of cancer.

MA48455A 2017-04-27 2018-04-27 ANTITUMOR COMPOUNDS MA48455B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382228 2017-04-27
PCT/EP2018/060868 WO2018197663A1 (en) 2017-04-27 2018-04-27 Antitumoral compounds

Publications (2)

Publication Number Publication Date
MA48455A MA48455A (en) 2020-03-04
MA48455B1 true MA48455B1 (en) 2023-06-28

Family

ID=58668823

Family Applications (3)

Application Number Title Priority Date Filing Date
MA57420A MA57420B1 (en) 2017-04-27 2018-04-27 ANTI-CANCER COMPOUNDS
MA48455A MA48455B1 (en) 2017-04-27 2018-04-27 ANTITUMOR COMPOUNDS
MA58643A MA58643B1 (en) 2017-04-27 2018-04-27 ANTI-CANCER COMPOUNDS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA57420A MA57420B1 (en) 2017-04-27 2018-04-27 ANTI-CANCER COMPOUNDS

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA58643A MA58643B1 (en) 2017-04-27 2018-04-27 ANTI-CANCER COMPOUNDS

Country Status (2)

Country Link
AR (1) AR114387A1 (en)
MA (3) MA57420B1 (en)

Also Published As

Publication number Publication date
AR114387A1 (en) 2020-09-02
MA57420B1 (en) 2023-06-28
MA58643B1 (en) 2023-09-27
MA48455A (en) 2020-03-04

Similar Documents

Publication Publication Date Title
MA44021B1 (en) Antitumor compounds
MA52486B1 (en) Pyridazinones used as parp7 inhibitors
MA38390A1 (en) Tetrahydropyrrolothiazine compounds
MA42795A (en) USEFUL THERAPEUTIC COMPOUNDS FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF HIV VIRUS INFECTION
MA39189A1 (en) Derivatives of 1h-indazole and 1h-indole antibacterials
EA201690153A1 (en) SUBSTITUTED PETROPHORANE AND BENZOXAZOLYL COMPOUNDS AND THEIR APPLICATIONS
MA38039A1 (en) Céphem compounds substituted in position 2
MA46337A (en) PYRIDINE COMPOUND
MA35342B1 (en) Piperidinyl compounds useful as inhibitors of tankyrase
MA38645A1 (en) New inhibitors of cyp17 / antiandrogens
MA40221A (en) ISOINDOLINE DERIVATIVES FOR USE IN THE TREATMENT OF VIRAL INFECTION
EA201791667A1 (en) BENZOXABOROL COMPOUNDS AND THEIR APPLICATION
FR3066761B1 (en) NEW IONIC CHANNEL INHIBITORS
MA39315A1 (en) Pyridazine derivatives for use in the prevention or treatment of ataxic disorder
MA39207A1 (en) Derivatives of isoquinoline, process for their preparation and pharmaceutical compositions containing them
MA38410A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MA39305A3 (en) Ethynyl derivatives
MA38857A1 (en) Derivatives of 1- (piperazin-1-yl) -2 - ([1,2,4] triazol-1-yl) -ethanone
FR3037953B1 (en) PROCESS FOR THE SYNTHESIS OF MOLECULES CARRYING AN OXIDE FUNCTION OF NITRILE
FR3020809B1 (en) 4-VINYL-2CYCLOPENTENE-1-ONE DERIVATIVES FOR THE PREPARATION THEREOF AND THEIR USE AS ANTIBIOTIC AGENT
MA48455B1 (en) ANTITUMOR COMPOUNDS
MA39529A1 (en) Highly effective stabilizing agent
MA20150280A2 (en) Arylethynyl derivatives
EA201891240A1 (en) 1,3,4-TIADIAZOLIC COMPOUNDS AND THEIR APPLICATION IN THE TREATMENT OF CANCER
FR3047665B1 (en) CELASTROL AND ITS DERIVATIVES IN THE TREATMENT OF PRE-CANCEROUS SKIN TUMORS AND PATHOLOGIES